HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne-Christine Bay-Jensen Selected Research

farglitazar

1/2022An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne-Christine Bay-Jensen Research Topics

Disease

19Osteoarthritis
01/2022 - 07/2008
14Inflammation (Inflammations)
01/2022 - 12/2011
11Pain (Aches)
01/2022 - 12/2011
10Fibrosis (Cirrhosis)
01/2022 - 01/2010
7Rheumatoid Arthritis
01/2021 - 04/2011
6Axial Spondyloarthritis
12/2022 - 01/2016
6Crohn Disease (Crohn's Disease)
12/2022 - 10/2015
6Knee Osteoarthritis
01/2021 - 01/2015
6Neoplasms (Cancer)
08/2017 - 03/2013
5Psoriatic Arthritis
08/2022 - 07/2017
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2022 - 10/2015
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2010
4Synovitis
01/2021 - 01/2015
3Obesity
01/2022 - 01/2021
3Necrosis
01/2019 - 07/2018
3Chronic Obstructive Pulmonary Disease (COPD)
07/2015 - 07/2010
2Disease Progression
01/2022 - 05/2015
2Overweight
01/2022 - 01/2021
2Systemic Scleroderma (Systemic Sclerosis)
01/2020 - 06/2019
2Non-Radiographic Axial Spondyloarthritis
05/2019 - 01/2019
2Pathologic Processes
01/2019 - 12/2011
2Bone Resorption
01/2019 - 12/2011
2Rheumatic Diseases (Rheumatism)
01/2019 - 04/2011
2type 2 alpha 1 Collagenopathy
01/2016 - 01/2009
2Joint Diseases (Joint Disease)
12/2011 - 04/2010
1Ankylosing Spondylitis
12/2022
1Colitis
12/2022
1Pathologic Constriction (Stenosis)
01/2022
1Pelvic Pain
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Back Pain (Backache)
01/2022
1Fistula
01/2022
1Infections
01/2022
1Hyperplasia
12/2021
1Body Weight (Weight, Body)
01/2021
1Insulin Resistance
01/2021
1Osteophyte
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020
1Skin Diseases (Skin Disease)
10/2020
1Hyperlipidemias (Hyperlipidemia)
10/2020
1Cognitive Dysfunction
10/2020
1Dementia (Dementias)
10/2020
1Primary Myelofibrosis (Myelosclerosis)
05/2020
1Thrombosis (Thrombus)
06/2019

Drug/Important Bio-Agent (IBA)

48Biomarkers (Surrogate Marker)IBA
12/2022 - 07/2008
18CollagenIBA
12/2022 - 01/2009
16Matrix Metalloproteinases (MMPs)IBA
01/2022 - 03/2011
11Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2010
8EpitopesIBA
09/2022 - 01/2010
7C-Reactive ProteinIBA
12/2022 - 07/2018
7catch-relaxing peptide (Mytilus)IBA
01/2022 - 07/2018
7VimentinIBA
01/2021 - 10/2014
6Collagen Type III (Type III Collagen)IBA
01/2022 - 03/2011
5EnzymesIBA
01/2022 - 04/2011
5Peptide Hydrolases (Proteases)FDA Link
01/2022 - 01/2010
5Collagen Type I (Type I Collagen)IBA
01/2021 - 10/2014
5Pharmaceutical PreparationsIBA
01/2019 - 07/2008
4Collagen Type IV (Type IV Collagen)IBA
12/2022 - 01/2016
4Extracellular Matrix ProteinsIBA
01/2022 - 01/2010
3ImmunosorbentsIBA
01/2022 - 04/2011
3Complement C3 (C3 Complement)IBA
01/2022 - 06/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2016
3Collagen Type II (Type II Collagen)IBA
01/2019 - 01/2009
3Metalloproteases (Metalloproteinases)IBA
08/2017 - 04/2011
2guselkumabIBA
08/2022 - 08/2022
2Monoclonal AntibodiesIBA
08/2022 - 01/2022
2Complement C4 (Complement Component 4)IBA
01/2022 - 01/2020
2collagen type I trimeric cross-linked peptideIBA
01/2022 - 01/2019
2tocilizumab (atlizumab)FDA Link
10/2020 - 07/2018
2Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2017
2Fibrinogen (Factor I)FDA Link
06/2019 - 01/2019
2Oncostatin MIBA
01/2019 - 01/2019
2salmon calcitonin (Calcimar)FDA LinkGeneric
01/2012 - 11/2010
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2012 - 04/2010
2Peptides (Polypeptides)IBA
11/2010 - 01/2010
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
09/2022
1LeptinIBA
01/2022
1farglitazarIBA
01/2022
1PAR-2 ReceptorIBA
12/2021
15'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA
10/2021
1PeroxidasinIBA
10/2021
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
10/2021
1Protein Glutamine gamma Glutamyltransferase 2IBA
10/2021
1Fish OilsIBA
06/2021
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2021
1Radioisotopes (Radionuclides)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1nintedanibIBA
10/2020
1Apolipoproteins E (ApoE)IBA
10/2020
1Infliximab (Remicade)FDA Link
01/2020
1Adalimumab (Humira)FDA Link
01/2020
1Factor XIII (Coagulation Factor XIII)IBA
06/2019
1FibrinIBA
06/2019
1fibrin fragment D (D-dimer)IBA
06/2019
1Phosphotransferases (Kinase)IBA
01/2019
1OsteocalcinIBA
01/2019

Therapy/Procedure

3Therapeutics
01/2021 - 07/2018
1Bariatric Surgery
01/2022
1Replacement Arthroplasty
12/2020
1Exercise Therapy (Therapy, Exercise)
01/2019